Deepintec Medical Technology Co., Ltd. was established in June 2020, focusing on providing "advanced and high-quality neurovascular intervention treatment solutions" for neurointerventional doctors. The company is headquartered in the Beijing Economic-Technological Development Area in Yizhuang, with an overseas R&D center in California, USA. The international R&D team has extensive experience in neurointerventional device development and a forward-looking vision, enabling them to develop high-quality medical devices by integrating clinical needs with cutting-edge international technologies.

Currently, the company has multiple neurointerventional products approved for market launch, and its products under development cover a comprehensive range of stroke intervention solutions, including cerebral hemorrhage, ischemia, acute stroke, and treatment access pathways. Meanwhile, the company has established a nationwide sales and promotion network to provide high-quality products and services to patients and healthcare professionals. Deepintec consistently adheres to independent R&D and manufacturing, maintaining high standards and stringent requirements throughout a full-process management system, embodying the principle of "in-depth research for precision devices, ensuring success through excellence."

ESG Goals

Green Innovation for Life and Health Protection: Develop safe, precise, and reliable neurointerventional solutions.

Lean Governance and Transparent Operations: Empower medical technology to build a sustainable future together.